Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,165.1
-19.5 (-0.61%)

 

  • STI Straits Times Index
    3,165.1
    -19.5 (-0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,606.8
    -5.4 (-0.34%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,457.1
    -241.7 (-0.84%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,412.9
    -37.7 (-1.09%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,538.7
    -229.3 (-0.77%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,959.8
    -110.4 (-1.82%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,347.1M
  • Value: 903.6M
  • Rise: 76
  • Fall: 256
  • Unch: 440

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.193-0.007
Jiutian Chemical0.098+0.006
Oceanus^0.041-0.002
Anchor Resources0.029+0.005
Thomson Medical0.113+0.001
Frasers L&C Tr1.470-
Golden Agri-Res0.215-
Mercurius0.062-0.008
Singtel2.420-0.010
ThaiBev0.760-0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,900.2 +70.9
HSI 28,436.4 -262.4
HSCEI 10,858.8 -118.6
Jakarta 5,966.1 -104.1
Nikkei 225 29,538.7 -229.3
SSE Comp 3,412.9 -37.7
Shanghai A 3,577.3 -39.5
Shanghai B 244.8 -2.7
KOSPI 3,135.6 +3.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VAXCYTE INC VAXCYTE
Updated on 09 Apr 2021 (End of trading day)
Last (USD): 20.220 Change: -0.540 High: 20.990 Remarks: -
Change (%): -2.60 Low: 19.850
Open 20.380 Yesterday's Close 20.759999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 301,918 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.73819 Trailing EPS (USD) e -1.73819 NAV (USD) b 6.7380
PE a - Trailing PE f - Price / NAV b 3.0009
Dividend (USD) d - Cash In Hand (USD) g 7.5242 Issued & Paid-up Shares c 51,327,600
Dividend Yield (%) d - Price / Cash In Hand g 2.687 Treasury Shares h -
Market Cap (M) 1,037.844 Enterprise Value (M) 651.644
Piotroski F Score 2 Exchange Code PCVX Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 54.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Jun 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VAXCYTE INC NASDAQ 1,037.844 - - 3.0009 -
Industry Biotechnology NASDAQ 2,873.159 106.306 106.381 6.6482 0.615
Local Peer AMGEN INC NASDAQ 143,345.908 19.734 19.734 15.2350 2.582
Local Peer GILEAD SCIENCES INC NASDAQ 81,817.226 665.202 665.181 4.4950 4.169
Local Peer ILLUMINA INC NASDAQ 58,851.683 89.713 89.713 12.5376 -
Local Peer MODERNA INC NASDAQ 56,393.366 - - 22.0167 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,462.466 20.453 20.453 6.3847 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 50,905.898 14.490 14.490 4.6172 -
Local Peer BIOGEN INC NASDAQ 40,851.945 10.211 10.211 3.8178 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,078.638 56.478 56.478 2.9249 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 29,499.375 1,702.774 1,702.673 17.5746 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 28,268.729 - - 7.3060 -
Local Peer SEAGEN INC NASDAQ 25,899.562 42.204 42.204 7.4251 -
Local Peer EXACT SCIENCES CORP NASDAQ 21,227.935 - - 7.5184 -
Other Local Peers 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ARVINAS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), INSTIL BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MACROGENICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CYTOKINETICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIOATLA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), IMMUNOGEN INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ALECTOR INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), CURIS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), HUMANIGEN INC (NASDAQ), PERSONALIS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CORTEXYME INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MERUS B V (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), INHIBRX INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VAXART INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KADMON HLDGS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), AGENUS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), AKOUOS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), AVROBIO INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), ATRECA INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SESEN BIO INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADICET BIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), ATHERSYS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), ONCORUS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), IMMUNOME INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NEXTCURE INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), BIOVIE INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), EVOGENE LTD (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), CHIASMA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), METACRINE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SYNLOGIC INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ORGENESIS INC (NASDAQ), LONGEVERON INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), OTONOMY INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), LUMOS PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), GEOVAX LABS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 119,878.608 38.223 31.499 11.3443 1.114
Global Peer WUXI BIO HKEx 426,774.028 224.877 224.879 17.5037 -
Global Peer BEIGENE HKEx 217,085.052 - - 7.2358 -
Global Peer SINO BIOPHARM HKEx 149,005.557 47.852 47.853 7.5043 -
Global Peer ZAI LAB-SB HKEx 88,816.418 - - 9.7957 -
Global Peer JOINN HKEx 37,237.832 105.198 105.198 25.6405 0.252
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,122.755 13.513 13.513 2.8492 -
Global Peer GENSCRIPT BIO HKEx 29,541.079 - - 4.2251 -
Global Peer 3SBIO HKEx 18,288.484 19.473 19.473 1.4430 -
Other Global Peers ARCUS BIOSCIENCES INC (NYSE), NUVATION BIO INC (NYSE), VIVA BIOTECH (HKEx), JW THERAP-B (HKEx), MYOVANT SCIENCES LTD (NYSE), JACOBIO-B (HKEx), KINTOR PHARMA-B (HKEx), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), ALPHAMAB-B (HKEx), FRONTAGE (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), JHBP-B (HKEx), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), LEE'S PHARM (HKEx), OPTHEA LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ENZO BIOCHEM INC (NYSE), BIOMX INC (NYSE American), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), LEAF RESOURCES LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), UNI-BIO GROUP (HKEx), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CT ENTERPRISE (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), MEMPHASYS LTD (ASX), PATRYS LIMITED (ASX), BIOTRON (ASX), Suntar Eco-City (SGX), AUSTRALIAN PRIMARY HEMP LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BIOSINO BIO-TEC (HKEx), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), CRYOSITE (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.710
-3.39 %
10 Days --3.540
-14.90 %
20 Days --6.160
-23.35 %
Medium Term Return 3 Months --5.990
-22.85 %
6 Months --28.380
-58.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 17.720 - 58.475 Change From 1 Year Low +2.500 % Change From 1 Year Low (%) +14.11
Change From 1 Year High -38.255 % Change From 1 Year High (%) -65.42
2 Years Range 17.720 - 58.475 Change From 2 Years Low +2.500 % Change From 2 Years Low (%) +14.11
Change From 2 Years High -38.255 % Change From 2 Years High (%) -65.42
5 Years Range 17.720 - 58.475 Change From 5 Years Low +2.500 % Change From 5 Years Low (%) +14.11
Change From 5 Years High -38.255 % Change From 5 Years High (%) -65.42
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Vaxcyte, Inc. engages in development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering, Ashish Khanna and Jeff Fairman on November 27, 2013 and is headquartered in Foster City, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
09 Apr 2021 20.380 20.990 19.850 20.220 301,918 -
08 Apr 2021 22.080 22.470 20.650 20.760 288,085 -
07 Apr 2021 21.530 22.130 21.100 21.850 257,345 -
06 Apr 2021 22.250 22.395 21.010 21.520 325,465 -
05 Apr 2021 21.280 22.360 21.035 22.240 279,456 -
01 Apr 2021 19.810 21.200 19.810 20.930 366,413 -
31 Mar 2021 18.600 20.000 17.720 19.750 685,237 -
30 Mar 2021 19.000 19.890 17.880 18.660 1,194,438 -
29 Mar 2021 23.490 23.490 22.429 22.730 277,903 -
26 Mar 2021 24.770 24.940 23.090 23.760 161,048 -
25 Mar 2021 21.590 24.660 21.350 24.530 318,185 -
24 Mar 2021 22.890 23.260 21.945 22.020 285,617 -
23 Mar 2021 23.390 23.540 22.350 22.790 615,599 -
22 Mar 2021 25.550 25.930 23.400 23.710 581,578 -
19 Mar 2021 26.060 26.940 25.280 25.410 2,827,332 -
18 Mar 2021 27.010 27.445 25.300 25.710 613,183 -
17 Mar 2021 26.650 28.300 26.095 27.250 584,682 -
16 Mar 2021 26.950 27.810 25.780 26.720 355,560 -
15 Mar 2021 26.280 28.000 26.240 27.070 342,764 -
12 Mar 2021 25.440 26.420 24.930 26.380 174,462 -
11 Mar 2021 23.660 25.900 23.340 25.740 322,445 -
10 Mar 2021 24.870 25.100 23.160 23.440 326,561 -
Summary
Current 2 Weeks
(26 Mar 2021 to 09 Apr 2021)
24.770 24.940 17.720 20.220 4,137,308 -
Previous 2 Weeks
(12 Mar 2021 to 25 Mar 2021)
25.440 26.420 17.720 24.530 6,698,962 -
4 Weeks from
(11 Feb 2021 to 11 Mar 2021)
26.930 27.490 17.720 25.740 7,718,314 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.